Protocatechuic acid inhibits lung cancer cells by modulating FAK, MAPK, and NF- B pathways

Nutrition and Cancer

Volumn 66, Issue 8, 2014, Pages 1331-1341

  Tsao, Shih Ming ^a,b   Hsia, Te Chun ^a,c   Yin, Mei Chin ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CASPASE 3; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTOCATECHUIC ACID; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; VASCULOTROPIN; BAX PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; HYDROXYBENZOIC ACID DERIVATIVE; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CALU 6 CELL LINE; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; H3255 CELL LINE; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; DRUG EFFECTS; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FIBRONECTINS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; HYDROXYBENZOATES; INTERLEUKIN-6; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84911439157     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.956259     Document Type: Article

References (33)

1. Chen CJ, You SL, Lin H, Hsu WL, and Yang YW: Cancer epidemiology and control in Taiwan: a brief review. Jpn J Clin Oncol 32, 66-81, 2002.
2. Walker S: Updates in non-small cell lung cancer. Clin J Oncol Nurs 12, 587-596, 2008.
3. Pasqualetti G, Ricciardi S, Mey V, Del Tacca M, and Danesi R: Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines. Lung Cancer 74, 197-205, 2011.
4. Huang CY, Lin CY, Tsai CW, and Yin MC: Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines. Toxicol In Vitro 25, 1274-1280, 2011.
5. Masella R, Santangelo C, D'Archivio M, Volti G, Giovannini C, et al.: Protocatechuic acid and human disease prevention: biological activities and molecular mechanisms. Curr Med Chem 19, 2901-2917, 2012.
6. Azzini E, Vitaglione P, Intorre F, Napolitano A, Durazzo A, et al.: Bioavailability of strawberry antioxidants in human subjects. Br J Nutr 104, 1165-1173, 2010.
7. Koli R, Erlund I, Jula A, Marniemi J, Mattila P, et al.: Bioavailability of various polyphenols from a diet containing moderate amounts of berries. J Agric Food Chem 58, 3927-3932, 2010.
8. Yin MC, Lin CC, Wu HC, Tsao SM, and Hsu CK: Apoptotic effects of protocatechuic acid in human breast, lung, liver, cervix, and prostate cancer cells: potential mechanisms of action. J Agric Food Chem 57, 6468-6473, 2009.
9. Leung HW, Yang WH, Lai MY, Lin CJ, and Lee HZ: Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 45, 403-411, 2007.
10. Lúcio KA, Rocha G, Monção-Ribeiro LC, Fernandes J, Takiya CM, et al.: Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo. PLoS One 6, e28596, 2011.
11. Han S, Ritzenthaler JD, Sitaraman SV, and Roman J: Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular- regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281, 29614-29624, 2006.
12. Park JK, Park SH, So K, Bae IH, Yoo YD, et al.: ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol 36, 181-192, 2010.
13. Dowlati A, Gray R, Sandler AB, Schiller JH, and Johnson DH: Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab-an Eastern Cooperative Oncology Group Study. Clin Cancer Res 14, 1407-1412, 2008.
14. Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, et al.: Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501. J Clin Oncol 27, 6006-6011, 2009.
15. Alam M, Wang JH, Coffey JC, Qadri SS, O'Donnell A, et al.: Characterization of the effects of cyclooxygenase-2 inhibition in the regulation of apoptosis in human small and non-small cell lung cancer cell lines. Ann Surg Oncol 14, 2678-2684, 2007.
16. Zhao J, Harper R, Barchowsky A, and Di YP: Identification of multiple MAPK-mediated transcription factors regulated by tobacco smoke in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 293, 480-490, 2007.
17. Shieh JM, Cheng TH, Shi MD, Wu PF, Chen Y, et al.: a-Tomatine suppresses invasion and migration of human non-small cell lung cancer NCIH460 cells through inactivating FAK/PI3K/Akt signaling pathway and reducing binding activity of NF-kB. Cell Biochem Biophys 60, 297-310, 2011.
18. Kausar H, Jeyabalan J, Aqil F, Chabba D, Sidana J, et al.: Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Lett 325, 54-62, 2012.
19. Torlinska T, and Grochowalska A: Age-related changes of NaC, KCATPase, Ca2C-ATPase and Mg2C-ATPase activities in rat brain synaptosomes. J Physiol Pharmacol 55, 457-465, 2004.
20. Yin W, Cheng W, Shen W, Shu L, Zhao J, et al.: Impairment of Na(C), K (C)-ATPase in CD95(APO-1)-induced human T-cell leukemia cell apoptosis mediated by glutathione depletion and generation of hydrogen peroxide. Leukemia 21, 1669-1678, 2007.
21. Einbond LS, Shimizu M, Ma H, Wu HA, Goldsberry S, et al.: Actein inhibits the NaC-KC-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem Biophys Res Commun 375, 608-613, 2008.
22. Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, et al.: Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate 67, 582-590, 2007.
23. Kim R, Emi M, Tanabe K, Murakami S, Uchida Y, et al.: Regulation and interplay of apoptotic and non-apoptotic cell death. J Pathol 208, 319-326, 2006.
24. Shou Y, Hirano T, Gong Y, Kato Y, Yoshida K, et al.: Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer. Br J Cancer 85, 1706-1712, 2001.
25. Ritzenthaler JD, Han S, and Roman J: Stimulation of lung carcinoma cell growth by fibronectin-integrin signaling. Mol Biosyst 4, 1160-1169, 2008.
26. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, et al.: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3, 589-601, 2003.
27. Liu G, Meng X, Jin Y, Bai J, Zhao Y, et al.: Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell Biol Int 32, 663-670, 2008.
28. Shih YW, Chien ST, Chen PS, Lee JH, Wu SH, et al.: Alpha-mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via alphavbeta3 integrin/FAK/ERK and NF-kappaB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem Biophys 58, 31-44, 2010.
29. Siejka A, Barabutis N, and Schally AV: GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro. Peptides 37, 63-68, 2012.
30. Yang HT, Chao PC, and Yin MC: Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration. J Food Sci 78, 343-349, 2013.
31. Lemmon CR, Woo JH, Tully E, Wilsbach K, and Gabrielson E: Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase. J Biol Chem 286, 3157-3165, 2011.
32. Germano G, Mantovani A, and Allavena P: Targeting of the innate immunity/ inflammation as complementary anti-tumor therapies. Ann Med 43, 581-593, 2011.
33. Suzuki R, Kohno H, Sugie S, and Tanaka T: Dietary protocatechuic acid during the progression phase exerts chemopreventive effects on chemically induced rat tongue carcinogenesis. Asian Pac J Cancer Prev 4, 319-326, 2003.